OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
Yihang Zhang, Jiazhen Wang
Advances in respiratory medicine (2023) Vol. 91, Iss. 1, pp. 26-48
Open Access | Times Cited: 23
Yihang Zhang, Jiazhen Wang
Advances in respiratory medicine (2023) Vol. 91, Iss. 1, pp. 26-48
Open Access | Times Cited: 23
Showing 23 citing articles:
MBNL2 promotes aging-related cardiac fibrosis via inhibited SUMOylation of Krüppel-like factor4
Jing Lü, Qi Zhao, Lu Wang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110163-110163
Open Access | Times Cited: 5
Jing Lü, Qi Zhao, Lu Wang, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110163-110163
Open Access | Times Cited: 5
Pulmonary fibrosis: pathogenesis and therapeutic strategies
Jianhai Wang, Kuan Li, De Hao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
Jianhai Wang, Kuan Li, De Hao, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 4
The role of vascularity and the fibrovascular interface in interstitial lung diseases
Jana Dietrich, Alice J. Kang, Birger Tielemans, et al.
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240080-240080
Open Access
Jana Dietrich, Alice J. Kang, Birger Tielemans, et al.
European Respiratory Review (2025) Vol. 34, Iss. 175, pp. 240080-240080
Open Access
Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review
Domenico Sambataro, Giulia Morina, Alessandro Libra, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 599-599
Open Access
Domenico Sambataro, Giulia Morina, Alessandro Libra, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 599-599
Open Access
Deciphering the interplay: circulating cell-free DNA, signaling pathways, and disease progression in idiopathic pulmonary fibrosis
Yeva Meshkovska, Barchinai Dzhuraeva, Chandraiah Godugu, et al.
3 Biotech (2025) Vol. 15, Iss. 4
Closed Access
Yeva Meshkovska, Barchinai Dzhuraeva, Chandraiah Godugu, et al.
3 Biotech (2025) Vol. 15, Iss. 4
Closed Access
Trends and hotspots in pulmonary fibrosis biomarker research: a bibliometric analysis
Lingling Wang, Jianliang Huang, Gavin Tan, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Lingling Wang, Jianliang Huang, Gavin Tan, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Insights into human respiratory microbiome under dysbiosis and its analysis tool
Mohamed M.I. Helal, Vinay Kumar Bari
Frontiers in Microbiomes (2025) Vol. 4
Open Access
Mohamed M.I. Helal, Vinay Kumar Bari
Frontiers in Microbiomes (2025) Vol. 4
Open Access
Research into the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula based on network pharmacology, metabolomics, and verification of AMPK/PPAR-γ pathway of active ingredients
L.W. Yan, M Jiang, Xinsheng Fan
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116773-116773
Closed Access | Times Cited: 9
L.W. Yan, M Jiang, Xinsheng Fan
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116773-116773
Closed Access | Times Cited: 9
Rising cases of drug‐induced pulmonary fibrosis: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS ) database, 2000–2022
Kenneth L. McCall, Kelsey R. Hennig, Zachary T. Abe, et al.
Pharmacoepidemiology and Drug Safety (2024) Vol. 33, Iss. 5
Open Access | Times Cited: 3
Kenneth L. McCall, Kelsey R. Hennig, Zachary T. Abe, et al.
Pharmacoepidemiology and Drug Safety (2024) Vol. 33, Iss. 5
Open Access | Times Cited: 3
Chlorogenic acid attenuates idiopathic pulmonary fibrosis: An integrated analysis of network pharmacology, molecular docking, and experimental validation
Juan Manuel Velázquez-Enríquez, Jovito Cesar Santos-Álvarez, Alma Aurora Ramírez-Hernández, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150672-150672
Closed Access | Times Cited: 3
Juan Manuel Velázquez-Enríquez, Jovito Cesar Santos-Álvarez, Alma Aurora Ramírez-Hernández, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150672-150672
Closed Access | Times Cited: 3
Integrating metabolomics and network pharmacology analysis to explore mechanism of Pueraria lobata against pulmonary fibrosis: involvement of arginine metabolism pathway
Hong Du, Meijuan Shao, Shangcheng Xu, et al.
Journal of Ethnopharmacology (2024) Vol. 332, pp. 118346-118346
Closed Access | Times Cited: 2
Hong Du, Meijuan Shao, Shangcheng Xu, et al.
Journal of Ethnopharmacology (2024) Vol. 332, pp. 118346-118346
Closed Access | Times Cited: 2
Neutrophils and Lymphocytes: Yin and Yang of Lung Fibrosis and Patient Outcome in Diffuse Interstitial Lung Diseases
Erika M. Novoa-Bolivar, José Antonio Ros, Sonia Pérez‐Fernández, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2439-2439
Open Access | Times Cited: 2
Erika M. Novoa-Bolivar, José Antonio Ros, Sonia Pérez‐Fernández, et al.
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2439-2439
Open Access | Times Cited: 2
The role of sphingosine-1-phosphate in the development and progression of Parkinson’s disease
Wang Wang, Yang Zhao, Guoxue Zhu
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
Wang Wang, Yang Zhao, Guoxue Zhu
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
Autophagy Modulation and Its Implications on Glioblastoma Treatment
Johnny Chen, Andrea Salinas Rodriguez, Maximiliano Arath Morales, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8687-8703
Open Access | Times Cited: 4
Johnny Chen, Andrea Salinas Rodriguez, Maximiliano Arath Morales, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8687-8703
Open Access | Times Cited: 4
May Small Airways Dysfunction (SAD) Play a Role in the Idiopathic Pulmonary Fibrosis (IPF) and May SAD Be a Therapeutic Target?
Dariusz Ziora
Advances in respiratory medicine (2024) Vol. 92, Iss. 5, pp. 348-355
Open Access | Times Cited: 1
Dariusz Ziora
Advances in respiratory medicine (2024) Vol. 92, Iss. 5, pp. 348-355
Open Access | Times Cited: 1
New therapeutic approaches for fibrosis: harnessing translational regulation
S.S. Gill, Richard H. Gomer
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 1
S.S. Gill, Richard H. Gomer
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 1
Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Sofía Tesolato, Juan Vicente-Valor, José Ramón Jarabo, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3257-3257
Open Access | Times Cited: 2
Sofía Tesolato, Juan Vicente-Valor, José Ramón Jarabo, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3257-3257
Open Access | Times Cited: 2
IPF-related new macrophage subpopulations and diagnostic biomarker identification - combine machine learning with single-cell analysis
Hao Zhang, Yuwei Yang, Yan Cao, et al.
Research Square (Research Square) (2024)
Open Access
Hao Zhang, Yuwei Yang, Yan Cao, et al.
Research Square (Research Square) (2024)
Open Access
IPF-related new macrophage subpopulations and diagnostic biomarker identification - combine machine learning with single-cell analysis
Hao Zhang, Yuwei Yang, Yan Cao, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access
Hao Zhang, Yuwei Yang, Yan Cao, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access
Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations
Fotios Sampsonas, Pinelopi Bosgana, Vasiliki Bravou, et al.
Genes (2024) Vol. 15, Iss. 7, pp. 934-934
Open Access
Fotios Sampsonas, Pinelopi Bosgana, Vasiliki Bravou, et al.
Genes (2024) Vol. 15, Iss. 7, pp. 934-934
Open Access
Trigonelline mitigates bleomycin-induced idiopathic pulmonary fibrosis in mice
Swapnil Gavhane, Chandrakant Gawli, Sachin Kumar, et al.
Asian Pacific Journal of Tropical Biomedicine (2024) Vol. 14, Iss. 9, pp. 391-400
Open Access
Swapnil Gavhane, Chandrakant Gawli, Sachin Kumar, et al.
Asian Pacific Journal of Tropical Biomedicine (2024) Vol. 14, Iss. 9, pp. 391-400
Open Access
Site-specific dimerization of interleukin-11 alleviates bleomycin-induced pulmonary fibrosis in mice
Sa Wang, Pengyu Wang, Xiaotong Song, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 204, pp. 106953-106953
Open Access
Sa Wang, Pengyu Wang, Xiaotong Song, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 204, pp. 106953-106953
Open Access
Blocking GP130 binding in interleukin-11 through site-specific PEGylation attenuates bleomycin-induced pulmonary fibrosis in mice
Sa Wang, Pengyu Wang, Minhui Zhang, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124916-124916
Closed Access
Sa Wang, Pengyu Wang, Minhui Zhang, et al.
International Journal of Pharmaceutics (2024) Vol. 667, pp. 124916-124916
Closed Access
Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Sofía Tesolato, Juan Vicente-Valor, José Ramón Jarabo, et al.
(2023)
Open Access | Times Cited: 1
Sofía Tesolato, Juan Vicente-Valor, José Ramón Jarabo, et al.
(2023)
Open Access | Times Cited: 1
